Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Letavernier

Showing results (41-50 of 152) with videos related to

Pageof 16
Sort By:
Kidney International|January 23, 2022
Noninvasive screening of vancomycin-associated cast nephropathyCédric Rafat, Jeremy Zaworski, Yosu Luque, et al.
Urolithiasis|January 9, 2021
Effect of parathyroidectomy on renal stone recurrencePierre-Yves Charles, Emmanuel Letavernier, Sophie Périé, et al.
The Journal of Investigative Dermatology|August 20, 2019
Preventing Calpain Externalization by Reducing ABCA1 Activity with Probenecid Limits Melanoma Angiogenesis and DevelopmentGuillaume Hanouna, Ellie Tang, Joëlle Perez, et al.
Kidney International|July 16, 2017
The Case | Epistasis and urolithiasisNathalie Tabibzadeh, Lynda Cheddani, Michel Daudon, et al.
Frontiers in Medicine|February 8, 2021
Encrusted Uropathy: A Comprehensive Overview-To the Bottom of the CrustEls Van de Perre, Gina Reichman, Deborah De Geyter, et al.
Joint Bone Spine|September 29, 2025
Novel CNNM2 variant causing hypomagnesemia and early-onset calcium pyrophosphate deposition disease: A case reportCaroline Robert, Léa Perrot, Alexia Zelus, et al.
Urolithiasis|May 27, 2025
Origin of monosodium urate Randall's plaquesEls Van de Perre, Elise Maréchal, Karl Martin Wissing, et al.
Lab on a Chip|February 26, 2024
Confining calcium oxalate crystal growth in a carbonated apatite-coated microfluidic channel to better understand the role of Randall's plaque in kidney stone formationSamantha Bourg, Karol Rakotozandriny, Ivan T Lucas, et al.
Clinical Kidney Journal|April 25, 2024
Kidney involvement in Wilson's disease: a review of the literatureJulien Dang, Kevin Chevalier, Emmanuel Letavernier, et al.
Circulation Research|February 9, 2008
Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertensionEmmanuel Letavernier, Joëlle Perez, Agnès Bellocq, et al.
Pageof 16

Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
Kidney International|January 23, 2022
Noninvasive screening of vancomycin-associated cast nephropathyCédric Rafat, Jeremy Zaworski, Yosu Luque, et al.
Urolithiasis|January 9, 2021
Effect of parathyroidectomy on renal stone recurrencePierre-Yves Charles, Emmanuel Letavernier, Sophie Périé, et al.
The Journal of Investigative Dermatology|August 20, 2019
Preventing Calpain Externalization by Reducing ABCA1 Activity with Probenecid Limits Melanoma Angiogenesis and DevelopmentGuillaume Hanouna, Ellie Tang, Joëlle Perez, et al.
Kidney International|July 16, 2017
The Case | Epistasis and urolithiasisNathalie Tabibzadeh, Lynda Cheddani, Michel Daudon, et al.
Frontiers in Medicine|February 8, 2021
Encrusted Uropathy: A Comprehensive Overview-To the Bottom of the CrustEls Van de Perre, Gina Reichman, Deborah De Geyter, et al.
Joint Bone Spine|September 29, 2025
Novel CNNM2 variant causing hypomagnesemia and early-onset calcium pyrophosphate deposition disease: A case reportCaroline Robert, Léa Perrot, Alexia Zelus, et al.
Urolithiasis|May 27, 2025
Origin of monosodium urate Randall's plaquesEls Van de Perre, Elise Maréchal, Karl Martin Wissing, et al.
Lab on a Chip|February 26, 2024
Confining calcium oxalate crystal growth in a carbonated apatite-coated microfluidic channel to better understand the role of Randall's plaque in kidney stone formationSamantha Bourg, Karol Rakotozandriny, Ivan T Lucas, et al.
Clinical Kidney Journal|April 25, 2024
Kidney involvement in Wilson's disease: a review of the literatureJulien Dang, Kevin Chevalier, Emmanuel Letavernier, et al.
Circulation Research|February 9, 2008
Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertensionEmmanuel Letavernier, Joëlle Perez, Agnès Bellocq, et al.
Pageof 16